Why the study?
Is catheter-based renal sympathetic denervation cost-effective in patients with resistant hypertension?
Is catheter-based renal sympathetic denervation cost-effective in patients with resistant hypertension?
Catheter-based renal sympathetic denervation is a cost-effective strategy for managing resistant hypertension, especially when performed earlier in the disease course.
May inform timing of renal denervation in resistant hypertension; extends economic models but requires prospective validation.
Renal sympathetic denervation is a cost-effective intervention for patients with resistant hypertension. Earlier treatment produces better cost-effectiveness ratios.
No takes yet. Share an insight, caveat, or question.
Dorenkamp et al. (2012) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: